Population-based impact on overall survival after the introduction of docetaxel as standard therapy for metastatic castration resistant prostate cancer

Robert R Zielinski, Arun Azad, Kim N Chi, Scott Tyldesely

Research output: Contribution to journalArticleResearchpeer-review

Original languageEnglish
Pages (from-to)520-523
Number of pages4
JournalCanadian Urological Association Journal
Volume8
Issue number7-8
DOIs
Publication statusPublished - 2014
Externally publishedYes

Cite this

@article{1cd231f28677456aa65cbebe9be9b1fd,
title = "Population-based impact on overall survival after the introduction of docetaxel as standard therapy for metastatic castration resistant prostate cancer",
author = "Zielinski, {Robert R} and Arun Azad and Chi, {Kim N} and Scott Tyldesely",
year = "2014",
doi = "10.5489/cuaj.2076",
language = "English",
volume = "8",
pages = "520--523",
journal = "Canadian Urological Association",
issn = "1920-1214",
number = "7-8",

}

Population-based impact on overall survival after the introduction of docetaxel as standard therapy for metastatic castration resistant prostate cancer. / Zielinski, Robert R; Azad, Arun; Chi, Kim N; Tyldesely, Scott.

In: Canadian Urological Association Journal, Vol. 8, No. 7-8, 2014, p. 520-523.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Population-based impact on overall survival after the introduction of docetaxel as standard therapy for metastatic castration resistant prostate cancer

AU - Zielinski, Robert R

AU - Azad, Arun

AU - Chi, Kim N

AU - Tyldesely, Scott

PY - 2014

Y1 - 2014

UR - http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4137017/pdf/cuaj-7-8-e520.pdf

U2 - 10.5489/cuaj.2076

DO - 10.5489/cuaj.2076

M3 - Article

VL - 8

SP - 520

EP - 523

JO - Canadian Urological Association

JF - Canadian Urological Association

SN - 1920-1214

IS - 7-8

ER -